Search scope:
排序: Display mode:
Xin-Jian LI MD, Min-Na CHENG MPH, Yu-Heng WANG MD, Sun MIAO MPH, Zong-Qi ZHANG PhD, Yi-Sheng CHEN MD, Wei LU PhD,
Frontiers of Medicine 2010, Volume 4, Issue 1, Pages 67-70 doi: 10.1007/s11684-010-0023-8
Keywords: hypertension community pharmacological adherence control of blood pressure
Hudan Pan, Yanfang Zheng, Zhongqiu Liu, Zhongwen Yuan, Rutong Ren, Hua Zhou, Ying Xie, Liang Liu
Frontiers of Medicine 2019, Volume 13, Issue 5, Pages 564-574 doi: 10.1007/s11684-018-0676-2
Keywords: rheumatoid arthritis traditional Chinese medicine pharmacological mechanism metabolism adjuvant-induced
Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients
Yang Sun,Chenze Li,Lina Zhang,Dong Hu,Xudong Zhang,Ting Yu,Min Tao,Dao Wen Wang,Xiaoqing Shen
Frontiers of Medicine 2017, Volume 11, Issue 1, Pages 53-61 doi: 10.1007/s11684-017-0502-2
Low adherence to secondary prevention medications (ATM) of patients after acute coronary syndromeA total of 2126 patients were classified under low adherence (proportion of days covered (PDC)<50%) and high adherence (PDC>50%) groups based on their performance after discharge.Moreover, in patients undergoing PCI, high adherence to P2Y12 antagonists decreased the risk of MACEHigh adherence to P2Y12 antagonists was associated with lower risk of MACE.
Keywords: acute coronary syndromes adherence to secondary prevention medications clinical outcome
Biological properties and clinical applications of berberine
Danyang Song, Jianyu Hao, Daiming Fan
Frontiers of Medicine 2020, Volume 14, Issue 5, Pages 564-582 doi: 10.1007/s11684-019-0724-6
Keywords: berberine Coptis chinensis pharmacological properties mechanism clinical applications
Cell Therapy: Pharmacological Intervention Enters a Third Era
Wei He
Engineering 2019, Volume 5, Issue 1, Pages 5-9 doi: 10.1016/j.eng.2018.11.017
A novel intravenous general anesthetic--- emulsified isoflurane: from bench to bedside
Cheng Zhou, Jin Liu
Frontiers of Medicine 2012, Volume 6, Issue 4, Pages 381-387 doi: 10.1007/s11684-012-0229-z
Keywords: emulsified isoflurane (EI) general anesthesia regional anesthesia organ protection anesthetic pharmacological
design of novel proton-pump inhibitors with reduced adverse effects
Xiaoyi Li, Hong Kang, Wensheng Liu, Sarita Singhal, Na Jiao, Yong Wang, Lixin Zhu, Ruixin Zhu
Frontiers of Medicine 2019, Volume 13, Issue 2, Pages 277-284 doi: 10.1007/s11684-018-0630-3
Keywords: proton-pump inhibitor adverse effect pharmacological mechanism toxicological mechanism pKa calculation
Title Author Date Type Operation
Effectiveness of lifestyle intervention for hypertension in Shanghai communities: Results from the Shanghai Hypertension Detail Management Program
Xin-Jian LI MD, Min-Na CHENG MPH, Yu-Heng WANG MD, Sun MIAO MPH, Zong-Qi ZHANG PhD, Yi-Sheng CHEN MD, Wei LU PhD,
Journal Article
Deciphering the pharmacological mechanism of Guan-Jie-Kang in treating rat adjuvant-induced arthritis
Hudan Pan, Yanfang Zheng, Zhongqiu Liu, Zhongwen Yuan, Rutong Ren, Hua Zhou, Ying Xie, Liang Liu
Journal Article
Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients
Yang Sun,Chenze Li,Lina Zhang,Dong Hu,Xudong Zhang,Ting Yu,Min Tao,Dao Wen Wang,Xiaoqing Shen
Journal Article
Biological properties and clinical applications of berberine
Danyang Song, Jianyu Hao, Daiming Fan
Journal Article
A novel intravenous general anesthetic--- emulsified isoflurane: from bench to bedside
Cheng Zhou, Jin Liu
Journal Article